These drugs reduce production of the abnormal transthyretin protein in the liver, which is responsible for many cases of cardiac amyloidosis. Doctors report that the medications have led to fewer ...

New drugs approved by the FDA are prolonging the lives of those affected.

An amyloidosis diagnosis can take upwards of 2 years.Initial symptoms often are nondescript, and irreversible organ damage frequently occurs before disease confirmation.

Researchers have identified a natural compound from pomegranate leaves and branches that can directly dismantle the protein aggregates responsible for transthyretin amyloidosis.

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is associated with a high risk of death. Until now, treatment has consisted of ...

ATTR amyloidosis results from the buildup of transthyretin in the body. It can be inherited or acquired and can affect your heart, kidneys, and nervous system. While there’s no cure, treatment can ...

H.C. Wainwright analyst Andrew Fein has maintained their bullish stance on PRTA stock, giving a Buy rating today. Andrew Fein’s Buy rating for Prothena’s stock is based on the promising potential of ...

With targeted treatment using both medical therapy for transthyretin-associated cardiac amyloidosis (ATTR-CA) and valve replacement for aortic stenosis (AS), patients with the dual pathology can fare ...

A research team at Kumamoto University has discovered that a natural compound found in pomegranate leaves and branches can ...

Researchers identified PGG, a pomegranate compound, as an amyloid disruptor that breaks down toxic transthyretin aggregates.

A research team in Kumamoto University has discovered that a natural compound found in pomegranate leaves and branches can ...

Owing to the low incidence of AL amyloidosis, large studies are scarce and hardly any randomized, controlled studies comparing different therapeutic regimens have been conducted. Comparison of studies ...